Research Article

Visual Hallucinations as Incidental Negative Effects of Virtual Reality on Parkinson’s Disease Patients: A Link with Neurodegeneration?

Table 2

Demographics and clinical characteristics of groups at baseline and eight years later at follow-up.

VHVR WVHVR P

Age baselineNS

Sex (m)18NS

EducationNS

MMSE Baseline
Follow-up
Baseline
Follow-up
NS
NS

Hoehn/Yahr stageBaseline
Follow-up
Baseline
Follow-up
NS

UPDRS part IIIBaseline
Follow-up
Baseline
Follow-up
NS

L-dopa eq/die (mg/day)Baseline 683.3
Follow-up 695
Baseline 788
Follow-up 633
NS
NS

DA therapy (%)Baseline 100
Follow-up 100
Baseline 30
Follow-up 70

VH (%)Baseline 0
Follow-up 100
Baseline 0
Follow-up 0

NPIBaseline
Follow-up
Baseline
Follow-up
NS
NS

FABBaseline
Follow-up
Baseline
Follow-up


All values represent mean (SD, when not otherwise stated).
MMSE = Mini Mental State Examination; NPI = Neuropsychiatry Inventory; FAB = Frontal Assessment Battery; UPDRS part III = Unified Parkinson’s Disease Rating Scale-subscale III; VH = visual hallucination in the real life.